NCT00530933

Brief Summary

The purpose of this study is to determine whether tibial nerve stimulation is an effective treatment for faecal incontinence.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2007

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

September 15, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 18, 2007

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2009

Completed
Last Updated

September 18, 2007

Status Verified

September 1, 2007

First QC Date

September 15, 2007

Last Update Submit

September 15, 2007

Conditions

Outcome Measures

Primary Outcomes (1)

  • The difference in the percentage of patients with a 20% reduction in episodes of faecal incontinence between the placebo and treatment groups.

    14 weeks

Secondary Outcomes (2)

  • The difference in the improvements in the St Mark's incontinence score, quality of life scales, and physiological parameters between the treatment and placebo groups.

    14 weeks

  • The difference in the improvements in the urinary symptoms between placebo and treatment groups.

    14 weeks

Study Arms (3)

1

SHAM COMPARATOR

Sham tibial nerve stimulation

Procedure: Sham transcutaneous tibial nerve stimulation

2

EXPERIMENTAL

Percutaneous tibial nerve stimulation

Procedure: Percutaneous posterior tibial nerve stimulation

3

EXPERIMENTAL

Transcutaneous tibial nerve stimulation

Procedure: Transcutaneous tibial nerve stimulation

Interventions

Once weekly for 30 minutes

2

30 minutes once weekly

3

Once weekly for 30 minutes

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18
  • Incontinence to solid or liquid faeces

You may not qualify if:

  • Previous congenital or acquired spinal injury, spinal tumour or spinal surgery
  • Neurological diseases, such as diabetic neuropathy, multiple sclerosis and Parkinson's disease
  • Peripheral vascular disease
  • Diabetes mellitus
  • Congenital anorectal malformations
  • Previous rectal surgery (rectopexy / resection) done \< 12 months ago (24 months for cancer)
  • Present evidence of external full thickness rectal prolapse
  • Chronic bowel diseases such as inflammatory bowel disease
  • Chronic diarrhoea, uncontrolled by drugs or diet
  • Anatomical limitations that would prevent successful placement of an electrode
  • Previous use of transcutaneous electrical nerve stimulation Stoma in situ

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Mark's Hospital

London, W9 3EF, United Kingdom

RECRUITING

Related Publications (1)

  • George AT, Kalmar K, Sala S, Kopanakis K, Panarese A, Dudding TC, Hollingshead JR, Nicholls RJ, Vaizey CJ. Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence. Br J Surg. 2013 Feb;100(3):330-8. doi: 10.1002/bjs.9000.

MeSH Terms

Conditions

Fecal Incontinence

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • James Hollingshead, MRCS

    London North West Healthcare NHS Trust

    PRINCIPAL INVESTIGATOR
  • Carolynne Vaizey, MD FRCS FCS

    London North West Healthcare NHS Trust

    STUDY DIRECTOR

Central Study Contacts

James Hollingshead, MRCS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 15, 2007

First Posted

September 18, 2007

Study Start

September 1, 2007

Study Completion

April 1, 2009

Last Updated

September 18, 2007

Record last verified: 2007-09

Locations